SPARC and neoplasm: The same patient with Stage IV disease and hypermethylation in 95% of CpG sites within the SPARC promoter from samples isolated from the tumour also had an area of the surrounding normal colon examined, and this showed hypermethylation in only 50% of the CpG sites.